Literature DB >> 1871037

The effects of formulation variables on the stability of freeze-dried human growth hormone.

M J Pikal1, K M Dellerman, M L Roy, R M Riggin.   

Abstract

Formulation often has a dramatic effect on degradation of proteins during the freeze-drying process as well as impacting on the "shelf-life" stability of the freeze-dried product. This research presents the results of a formulation optimization study of the "in-process" and shelf-life stability of freeze-dried human growth hormone (hGH). Chemical decomposition via methionine oxidation and deamidation of asparagine residues as well as irreversible aggregation were characterized by HPLC assay methodology. In-process degradation and stability of low moisture freeze-dried solids were studied at 25 and 40 degrees C in a nominal nitrogen headspace (approximately 0.5% O2). Formulation variables included pH, level of salts, and the nature of the lyoprotectant. Studies of the effect of shear on aggregation in solutions indicated that shear comparable to that experienced during filtration does not induce aggregation. Irreversible changes in hGH during the freeze-drying process were minimal, but chemical decomposition via methionine oxidation and asparagine deamidation and aggregation did occur on storage of the freeze-dried solid. Decomposition via methionine oxidation was significant. A combination of mannitol and glycine, where the glycine remains amorphous, provided the greatest protection against decomposition and aggregation. It is postulated that an excipient system that remains at least partially amorphous is necessary for stabilization. However, the observation that dextran 40 formulations showed poor stability toward aggregation demonstrates that an amorphous excipient system is not a sufficient condition for stability. Stability of the solid was optimal when produced from solutions in the pH range, 7-7.5, with severe aggregation being observed at high pH. The level of sodium phosphate buffer affected stability of the solid, although this relationship was complex. Freeze-drying in the presence of NaCl produced severe aggregation and precipitation during the freeze-drying process as well as acceleration of oxidation and/or deamidation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1871037     DOI: 10.1023/a:1015834724528

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone.

Authors:  M J Pikal; K Dellerman; M L Roy
Journal:  Dev Biol Stand       Date:  1992

2.  Overview of the stability and handling of recombinant protein drugs.

Authors:  J Geigert
Journal:  J Parenter Sci Technol       Date:  1989 Sep-Oct

3.  A reversed-phase high-performance liquid chromatographic method for characterization of biosynthetic human growth hormone.

Authors:  R M Riggin; G K Dorulla; D J Miner
Journal:  Anal Biochem       Date:  1987-11-15       Impact factor: 3.365

4.  Chemical, physical, and biological characterization of a dimeric form of biosynthetic human growth hormone.

Authors:  G W Becker; R R Bowsher; W C Mackellar; M L Poor; P M Tackitt; R M Riggin
Journal:  Biotechnol Appl Biochem       Date:  1987-12       Impact factor: 2.431

5.  Enzyme inactivation with shearing.

Authors:  S E Charm; B L Wong
Journal:  Biotechnol Bioeng       Date:  1970-11       Impact factor: 4.530

6.  The mechanisms of irreversible enzyme inactivation at 100C.

Authors:  T J Ahern; A M Klibanov
Journal:  Science       Date:  1985-06-14       Impact factor: 47.728

7.  Physical chemistry of freeze-drying: measurement of sublimation rates for frozen aqueous solutions by a microbalance technique.

Authors:  M J Pikal; S Shah; D Senior; J E Lang
Journal:  J Pharm Sci       Date:  1983-06       Impact factor: 3.534

8.  Stability and functional properties of haemoglobin freeze-dried in the presence of four protective substances after prolonged storage: dose-effect relationships.

Authors:  P Labrude; C Vigneron
Journal:  J Pharm Pharmacol       Date:  1983-01       Impact factor: 3.765

9.  Haemoglobin lyophilized with sucrose: the effect of residual moisture on storage.

Authors:  T I Pristoupil; M Kramlová; H Fortová; S Ulrych
Journal:  Haematologia (Budap)       Date:  1985

10.  Isolation and characterization of a sulfoxide and a desamido derivative of biosynthetic human growth hormone.

Authors:  G W Becker; P M Tackitt; W W Bromer; D S Lefeber; R M Riggin
Journal:  Biotechnol Appl Biochem       Date:  1988-08       Impact factor: 2.431

View more
  44 in total

1.  Formation and isolation of spherical fine protein microparticles through lyophilization of protein-poly(ethylene glycol) aqueous mixture.

Authors:  T Morita; Y Horikiri; H Yamahara; T Suzuki; H Yoshino
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

2.  Microcalorimetric measurement of the interactions between water vapor and amorphous pharmaceutical solids.

Authors:  David Lechuga-Ballesteros; Aziz Bakri; Danforth P Miller
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

3.  Development of a stable freeze-dried formulation of recombinant human interleukin-1 receptor antagonist.

Authors:  B S Chang; G Reeder; J F Carpenter
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

4.  Freeze-drying of proteins from a sucrose-glycine excipient system: effect of formulation composition on the initial recovery of protein activity.

Authors:  Wei Liu; D Q Wang; Steven L Nail
Journal:  AAPS PharmSciTech       Date:  2005-09-30       Impact factor: 3.246

5.  Formulation and stabilization of Francisella tularensis live vaccine strain.

Authors:  Satoshi Ohtake; Russell A Martin; Atul Saxena; David Lechuga-Ballesteros; Araceli E Santiago; Eileen M Barry; Vu Truong-Le
Journal:  J Pharm Sci       Date:  2011-04-13       Impact factor: 3.534

6.  Determination of end point of primary drying in freeze-drying process control.

Authors:  Sajal M Patel; Takayuki Doen; Michael J Pikal
Journal:  AAPS PharmSciTech       Date:  2010-01-08       Impact factor: 3.246

7.  Stabilization of lyophilized porcine pancreatic elastase.

Authors:  B S Chang; C S Randall; Y S Lee
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

8.  Effect of N-1 and N-2 residues on peptide deamidation rate in solution and solid state.

Authors:  Bei Li; Richard L Schowen; Elizabeth M Topp; Ronald T Borchardt
Journal:  AAPS J       Date:  2006-03-20       Impact factor: 4.009

9.  Effective inhibition of mannitol crystallization in frozen solutions by sodium chloride.

Authors:  Chitra Telang; Lian Yu; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

10.  Aggregates formed during storage of beta-galactosidase in solution and in the freeze-dried state.

Authors:  S Yoshioka; Y Aso; K Izutsu; T Terao
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.